Articles

New Light Shed on Timing of Large-Scale Medtronic MiniMed Voluntary Recall

The move was made just a week after the FDA met with hackers who created an app to expose the vulnerability of the older insulin pumps, according to a Wired report.

Jada Louis Died Because She Had to Choose Between Paying for Rent or Insulin

A young woman from Virginia dies from insulin rationing. Read her story and share the resources we provide to help others avoid who might be in the same situation.

Sanofi Negotiating with Biocorp to Integrate Mallya Smart Cap to its Care Platform

Sanofi’s $4 million investment comes shortly after news that Biocorp has gained European approval for its smart cap as a new class of medical device.

Senator Bernie Sanders to Accompany Insulin Caravan to Canada

This marks the first time that a presidential candidate has pledged to take part in direct diabetes activism.

Trump Administration Drops Proposal Banning Drug Rebates for Medicare

It is the second setback against the administration’s efforts to bring down the high price of prescription drugs in the United States.

A Missed Type 1 Diabetes Diagnosis Increases Risk of Diabetic Ketoacidosis by 18%

That was just one of the troubling findings about the perils of misdiagnosing type 1 diabetes in a study conducted by T1D Exchange.

Disney World Gets Even More Magical

Disney World Gets Even More Magical

The T1D Exchange Registry will be recruiting at Friends for Life, an annual fun-filled gathering for families affected by type 1 diabetes.

One Drop Glucose Monitoring System Now Available at Select Apple Stores

Individuals with diabetes will now be able to purchase the One Drop system at select Apple Stores. Previously, Apple sold the glucose monitoring system online.

Utah Family Sues School After Son With Type 1 Diabetes Barred From Classes

The school district argues that their policy on medication bars school staff from administering diluted insulin.

Novo Nordisk CEO Believes Roughly 10% of Customers Are Struggling to Afford Insulin

The statement goes against a widely cited study which says one in four people with type 1 diabetes ration insulin because of unaffordability. See what else CEO Lars Fruergaard Jørgensen said about the insulin pricing crisis in a recent Stat+ interview.